Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma

References

• BosettiCTuratiFLa VecchiaCHepatocellular carcinoma epidemiologyBest Pract Res Clin Gastroenterol201428575377025260306
   PubMed Web of Science ®Google Scholar
• JemalACenterMMDesantisCWardEMGlobal patterns of cancer incidence and mortality rates and trendsCancer Epidemiol Biomarkers Prev20101981893190720647400
   PubMed Web of Science ®Google Scholar
• FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
   PubMed Web of Science ®Google Scholar
• GoldmanRRessomHWAbdel-HamidMCandidate markers for the detection of hepatocellular carcinoma in low-molecular weight fraction of serumCarcinogenesis200728102149215317724376
   PubMed Web of Science ®Google Scholar
• El-SeragHBMarreroJARudolphLReddyKRDiagnosis and treatment of hepatocellular carcinomaGastroenterology200813461752176318471552
   PubMed Web of Science ®Google Scholar
• MolasyMWalczakASzaflikJSzaflikJPMajsterekIMicroR-NAs in glaucoma and neurodegenerative diseasesJ Hum Genet201762110511227412874
   PubMed Web of Science ®Google Scholar
• ZhangELGuJZhangZYDongKSLiangBYHuangZYMicroRNA expression profiling in patients with hepatocellular carcinoma of familial aggregation and hepatitis B virus infectionOncol Lett201714197197628693260
   PubMed Web of Science ®Google Scholar
• PontissoPCalabreseFBenvegnùLOverexpression of squamous cell carcinoma antigen variants in hepatocellular carcinomaBr J Cancer200490483383714970861
   PubMed Web of Science ®Google Scholar
• YuenMFTanakaYFongDYIndependent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis BJ Hepatol2009501808818977053
   PubMed Web of Science ®Google Scholar
• TrevisaniFDe NotariisSRapacciniGSemiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experienceAm J Gastroenterol200297373474411922571
   PubMed Web of Science ®Google Scholar
• PozzanCCardinRPiciocchiMDiagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC)J Gastroenterol Hepatol20142981637164424635038
   PubMed Web of Science ®Google Scholar
• TsuchiyaNSawadaYEndoISaitoKUemuraYNakatsuraTBiomarkers for the early diagnosis of hepatocellular carcinomaWorld J Gastroenterol20152137105731058326457017
   PubMed Web of Science ®Google Scholar
• PengYCChanCSChenGHThe effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinomaHepatogastroenterology199946303208321110626187
   PubMedGoogle Scholar
• GuerraJGarenneMMohamedMKFontanetAHCV burden of infection in Egypt: results from a nationwide surveyJ Viral Hepat201219856056722762140
   PubMed Web of Science ®Google Scholar
• BerryVAroraRPaulPHepatitis C clinical outcome and diagnosisJ K Sci200573129131
   Google Scholar
• MotawiTKShakerOGEl-MaraghySASenousyMASerum microRNAs as potential biomarkers for early diagnosis of hepatitis C virus-related hepatocellular carcinoma in Egyptian patientsPLoS One2015109e013770626352740
   PubMed Web of Science ®Google Scholar
• TsaiJFJengJEChuangLYSerum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinomaScand J Gastroenterol2005401687515841717
   PubMed Web of Science ®Google Scholar
• ImaiKBeppuTChikamotoAComparison between hepatic resection and radiofrequency ablation as first-line treatment for solitary small-sized hepatocellular carcinoma of 3 cm or lessHepatol Res201343885386423281579
   PubMed Web of Science ®Google Scholar
• ZekriANYoussefASEl-DesoukyEDSerum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infectionTumour Biol2016379122731228627271989
   PubMedGoogle Scholar
• YangLXuQXieHGuGJiangJExpression of serum miR-218 in hepatocellular carcinoma and its prognostic significanceClin Transl Oncol201618884184726586116
   PubMed Web of Science ®Google Scholar
• ZuoDChenLLiuXCombination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinomaTumour Biol20163756539654926637228
   PubMedGoogle Scholar
• GuiJTianYWenXSerum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologiesClin Sci2011120518319320815808
   PubMed Web of Science ®Google Scholar
• AliSAlahmadyZZYamanyHAAbul-FotouhAMSerum expression levels of miR-141 and miR-215 for differentiation between liver cirrhosis, chronic hepatitis C and hepatocellular carcinoma patientsMicrobiol Res J Int2017203
   Google Scholar
• YangYMLeeWHLeeCGGα12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinomaOncogene201534222910292125065598
   PubMed Web of Science ®Google Scholar
• MamdouhSKhorshedFAboushoushaTEvaluation of mir-224, mir-215 and mir-143 as serum biomarkers for HCV associated hepatocellular carcinomaAsian Pac J Cancer Prev201718113167317129172295
   PubMedGoogle Scholar
• ZhangZQMengHWangNSerum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinomaDiagn Pathol2014913524993656
   PubMed Web of Science ®Google Scholar
• LiuFYouXChiXHepatitis B virus X protein mutant HBxΔ127 promotes proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRTBiochem Biophys Res Commun2014444212813424434140
   PubMed Web of Science ®Google Scholar
• WangLWangYMXuSMicroRNA-215 is upregulated by treatment with Adriamycin and leads to the chemoresistance of hepatocellular carcinoma cells and tissuesMol Med Rep20151245274528026135967
   PubMed Web of Science ®Google Scholar
• El-HalawanyMSIsmailHMZeeneldinAAInvestigating the pretreatment miRNA expression patterns of advanced hepatocellular carcinoma patients in association with response to TACE treatmentBiomed Res Int20152015112
   Web of Science ®Google Scholar
• RenYShangJLiJThe long noncoding RNA PCAT-1 links the microRNA miR-215 to oncogene CRKL-mediated signaling in hepatocellular carcinomaJ Biol Chem201729243179391794928887306
   PubMed Web of Science ®Google Scholar
• AshmawyAMElgeshyKMAbdel SalamETCrosstalk between liver-related microRNAs and Wnt/β-catenin pathway in hepatocellular carcinoma patientsArab J Gastroenterol201718314415028958640
   PubMed Web of Science ®Google Scholar
• BraconiCValeriNGaspariniPHepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytesClin Cancer Res201016395796620103677
   PubMed Web of Science ®Google Scholar
• GongJZhangJPLiBMicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6ROncogene201332253071307922824797
   PubMed Web of Science ®Google Scholar
• ShimizuSTakeharaTHikitaHThe let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinomaJ Hepatol201052569870420347499
   PubMed Web of Science ®Google Scholar
• ElemeeryMNBadrANMohamedMAGhareebDAValidation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patientsWorld J Gastroenterol201723213864387528638226
   PubMed Web of Science ®Google Scholar
• WhiteNMKhellaHWGrigullJmiRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215Br J Cancer2011105111741174922033272
   PubMed Web of Science ®Google Scholar
• DengYHuangZXuYMiR-215 modulates gastric cancer cell proliferation by targeting RB1Cancer Lett20143421273523981575
   PubMed Web of Science ®Google Scholar
• YeMZhangJZhangJMiaoQYaoLZhangJCurcumin promotes apoptosis by activating the p53-miR-192-5p/215-XIAP pathway in non-small cell lung cancerCancer Lett2015357119620525444916
   PubMed Web of Science ®Google Scholar
• ChenZHanSHuangWMicroRNA-215 suppresses cell proliferation, migration and invasion of colon cancer by repressing Yin-Yang 1Biochem Biophys Res Commun2016479348248827663660
   PubMed Web of Science ®Google Scholar
• HuJSunTWangHMiR-215 is induced post-transcriptionally via HIF-Drosha complex and mediates glioma-initiating cell adaptation to hypoxia by targeting KDM1BCancer Cell2016291496026766590
   PubMed Web of Science ®Google Scholar
• WangYXZhangTJYangDQReduced miR-215 expression predicts poor prognosis in patients with acute myeloid leukemiaJpn J Clin Oncol201646435035626802165
   PubMed Web of Science ®Google Scholar
• BraunCJZhangXSavelyevaIp53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrestCancer Res20086824100941010419074875
   PubMed Web of Science ®Google Scholar
• GeorgesSABieryMCKimSYCoordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215Cancer Res20086824101051011219074876
   PubMed Web of Science ®Google Scholar
• HusseinMMIbrahimAAAbdellaHMMontasserIFHassanMIEvaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patientsIndian J Cancer200845416717219112206
   PubMedGoogle Scholar
• El EzawyHShebilNMounisAAssessment of serum SCCA and KL-6 as tumor markers and their correlation with tumor sizeJ Am Sci2012172179
   Google Scholar
• MossadNAMahmoudEHOsmanEAMahmoudSHShoushaHIEvaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinomaTumour Biol20143511115591156425129443
   PubMedGoogle Scholar
• SoyemiOMOtegbayoJAOlaSOAkereASoyemiTComparative diagnostic efficacy of serum squamous cell carcinoma antigen in hepatocellular carcinomaBMC Res Notes20125140322856336
   PubMedGoogle Scholar
• DemerdashHMHussienHMHassounaEAridaEADetection of microRNA in hepatic cirrhosis and hepatocellular carcinoma in hepatitis C genotype-4 in Egyptian patientsBiomed Res Int20172017110
   Web of Science ®Google Scholar
• HarfoushRAHMeheissenMAElwafaRAHAElwazzanDAThe role of circulating microRNAs as markers of disease progression in hepatitis C virus infected Egyptian patientsAdv Microbiol201664320331
   Google Scholar
• SunJXShiJLiNPortal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinomaCancer Biol Med201613445245828154776
   PubMed Web of Science ®Google Scholar
• JangESJeongSHKimJWChoiYSLeissnerPBrechotCDiagnostic performance of alpha-fetoprotein, protein induced by vitamin K absence, osteopontin, Dickkopf-1 and its combinations for hepatocellular carcinomaPLoS One2016113e015106926986465
   PubMed Web of Science ®Google Scholar
• Samie El-SherifAAKamal EldinAMHigaziAKeryakosHMohamedHIRahman MeshrefDADiagnostic outcomes of soluble major histocompatibility complex class I related chain molecule A and Des-γ carboxy prothrombin versus alpha-fetoprotein for hepatitis C virus-induced hepatocellular carcinoma in Egyptian patientsImmunome Res2016123212
   Google Scholar
• LoosenSHSchuellerFTrautweinCRoySRoderburgCRole of circulating microRNAs in liver diseasesWorld J Hepatol201791258659428515844
   PubMed Web of Science ®Google Scholar
• MishraPJMerlinoGMicroRNA reexpression as differentiation therapy in cancerJ Clin Invest200911982119212319620782
   PubMed Web of Science ®Google Scholar
• MishraPJMicroRNAs as promising biomarkers in cancer diagnosticsBiomark Res201421925356314
   PubMedGoogle Scholar
• SempereLFRecent advances in miRNA-based diagnostic applicationsExpert Rev Mol Diagn201212655755922845475
   PubMedGoogle Scholar
• BraseJCJohannesMSchlommTCirculating miRNAs are correlated with tumor progression in prostate cancerInt J Cancer2011128360861620473869
   PubMed Web of Science ®Google Scholar
• LuMKongXWangHHuangGYeCHeZA novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosisOncotarget2017858775878428060739
   PubMedGoogle Scholar
• GiannelliGFransveaETrerotoliPClinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patientsClin Chim Acta20073831–214715217582392
   PubMed Web of Science ®Google Scholar
• BuccioneDFattiGGallottaASerum SCCA-IgM as a predictor of hepatocellular carcinoma in patients with liver cirrhosisOpen J Gastroenterol201202025661
   Google Scholar